2020 Case CCC Drug Discovery Census

To improve the discovery and advancement of innovative cancer therapeutics, the Case Comprehensive Cancer Center (Case CCC) has initiated a Drug Discovery Initiative and is providing seed funding toward the development of novel cancer therapeutics. To access funding, investigators must participate in the decennial Case CCC Drug Discovery Census. All therapeutic approaches and modalities are welcome! Projects at all stages are welcome! BE COUNTED!  The Census is simple to complete and open to all Case CCC Members. Applications will be accepted until August 1, 2020.

Award Description

  • Awards will be milestone-based and project-specific.

  • Our aim is to select a number of projects for seed funding and to continue to support projects that achieve key milestones.

  • Total funds committed to this RFA are $250,000.

  • Note that projects proposing small-molecule approaches will be considered for additional funding opportunities.

Funding Criteria

  • Open to all Case CCC members

  • Potential targets and approaches must be supported by a compelling rationale to be deemed responsive for this RFA.

  • While investigators can contribute more than one project to the Census, only one application will be funded per lead PI.

Completing the Census is simple! Use the Census form to answer the following four questions:

  1. What is your therapeutic hypothesis? (1 sentence)

  2. Where are you in the project? (2 sentences)

  3. What immediate next step would benefit from Case CCC support? (1 sentence)

  4. What would that cost? (a dollar figure)

Deadline

Applications will be accepted until August 1, 2020.

Complete the census to apply via InfoReady

Contact casecccpilots@case.edu or Julie DeJager Glavic (216.368.5780) with any questions.